×
About 1,245 results

ALLMedicine™ Recurrent Respiratory Papillomatosis Center

Research & Reviews  611 results

Initial Experience Treating HPV-Related Laryngeal Diseases with Oral Brincidofovir: A P...
https://doi.org/10.1177/00034894211007227
The Annals of Otology, Rhinology, and Laryngology; Richardson BE

Apr 9th, 2021 - To determine if brincidofovir, an oral analog of cidofovir that achieves high tissue levels of the active metabolite with low systemic toxicity, has an observable effect on HPV-related disease of the larynx. Two patients with laryngeal recurrent r...

How Enhancing Immunity to Low-Risk HPV Could Cure Recurrent Respiratory Papillomatosis.
https://doi.org/10.1002/lary.29153
The Laryngoscope; Bai K, Allen C

Mar 15th, 2021 - Recurrent respiratory papillomatosis (RRP) is currently treated with repeat surgical resection of papillomatous disease that does not address the fundamental underlying issue of chronic infection with low-risk human papillomavirus. Here, we review...

Sublesional Bevacizumab Injection for Recurrent Respiratory Papillomatosis: Evaluation ...
https://doi.org/10.1177/0003489421998215
The Annals of Otology, Rhinology, and Laryngology; Hall SR, Thiriveedi M et. al.

Mar 2nd, 2021 - The goal of this study was to evaluate the benefit of sublesional bevacizumab injection for recurrent respiratory papillomatosis (RRP) as used in a typical clinical practice. A retrospective review of patients with RRP treated between 2011 and 201...

Significant Declines in Juvenile Onset Recurrent Respiratory Papillomatosis following H...
https://doi.org/10.1093/cid/ciab171
Clinical Infectious Diseases : an Official Publication Of... Meites E, Stone L et. al.

Feb 23rd, 2021 - Juvenile onset recurrent respiratory papillomatosis (JORRP) is a rare and serious disease caused by human papillomavirus (HPV) presumably acquired during vaginal delivery. HPV vaccination of females through age 26 years, recommended in the United ...

Association between the TAP1 gene polymorphisms and recurrent respiratory papillomatosi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059727
Journal of Clinical Laboratory Analysis; Palomares-Marin J, Govea-Camacho LH et. al.

Jan 28th, 2021 - Recurrent respiratory papillomatosis (RRP) is a respiratory tract disease that affects children and adults and is characterized by the recurrent proliferation of multiple papillomas. The etiologic agent is the human papillomavirus, mainly genotype...

see more →

Guidelines  2 results

International Pediatric Otolaryngology Group (IPOG): Juvenile-onset recurrent respirato...
https://doi.org/10.1016/j.ijporl.2019.109697
International Journal of Pediatric Otorhinolaryngology; Lawlor C, Balakrishnan K et. al.

Nov 7th, 2019 - To develop consensus recommendations for the evaluation and management of juvenile-onset recurrent respiratory papillomatosis (JORRP) in pediatric patients. Expert opinion by the members of the International Pediatric Otolaryngology Group (IPOG). ...

2015 Sexually Transmitted Diseases Treatment Guidelines- Human Papillomavirus (HPV) Infection
https://www.cdc.gov/std/tg2015/hpv.htm

Jun 4th, 2015 - Approximately 100 types of human papillomavirus infection (HPV) have been identified, at least 40 of which can infect the genital area (758). Most HPV infections are self-limited and are asymptomatic or unrecognized.

see more →

Clinicaltrials.gov  625 results

Initial Experience Treating HPV-Related Laryngeal Diseases with Oral Brincidofovir: A P...
https://doi.org/10.1177/00034894211007227
The Annals of Otology, Rhinology, and Laryngology; Richardson BE

Apr 9th, 2021 - To determine if brincidofovir, an oral analog of cidofovir that achieves high tissue levels of the active metabolite with low systemic toxicity, has an observable effect on HPV-related disease of the larynx. Two patients with laryngeal recurrent r...

How Enhancing Immunity to Low-Risk HPV Could Cure Recurrent Respiratory Papillomatosis.
https://doi.org/10.1002/lary.29153
The Laryngoscope; Bai K, Allen C

Mar 15th, 2021 - Recurrent respiratory papillomatosis (RRP) is currently treated with repeat surgical resection of papillomatous disease that does not address the fundamental underlying issue of chronic infection with low-risk human papillomavirus. Here, we review...

Sublesional Bevacizumab Injection for Recurrent Respiratory Papillomatosis: Evaluation ...
https://doi.org/10.1177/0003489421998215
The Annals of Otology, Rhinology, and Laryngology; Hall SR, Thiriveedi M et. al.

Mar 2nd, 2021 - The goal of this study was to evaluate the benefit of sublesional bevacizumab injection for recurrent respiratory papillomatosis (RRP) as used in a typical clinical practice. A retrospective review of patients with RRP treated between 2011 and 201...

Significant Declines in Juvenile Onset Recurrent Respiratory Papillomatosis following H...
https://doi.org/10.1093/cid/ciab171
Clinical Infectious Diseases : an Official Publication Of... Meites E, Stone L et. al.

Feb 23rd, 2021 - Juvenile onset recurrent respiratory papillomatosis (JORRP) is a rare and serious disease caused by human papillomavirus (HPV) presumably acquired during vaginal delivery. HPV vaccination of females through age 26 years, recommended in the United ...

Association between the TAP1 gene polymorphisms and recurrent respiratory papillomatosi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059727
Journal of Clinical Laboratory Analysis; Palomares-Marin J, Govea-Camacho LH et. al.

Jan 28th, 2021 - Recurrent respiratory papillomatosis (RRP) is a respiratory tract disease that affects children and adults and is characterized by the recurrent proliferation of multiple papillomas. The etiologic agent is the human papillomavirus, mainly genotype...

see more →

News  5 results

HPV vaccination cuts incidence of juvenile respiratory papillomatosis
https://www.mdedge.com/pulmonary-health-hub/article/151785/vaccines/hpv-vaccination-cuts-incidence-juvenile-respiratory
Bianca Nogrady

Nov 12th, 2017 - Introduction of a national human papillomavirus vaccination program in Australia has been associated with declines in the incidence of juvenile-onset recurrent respiratory papillomatosis, according to a nationwide study. Juvenile-onset recurrent r.

Quadrivalent HPV Vaccine Found Effective in Males
https://www.mdedge.com/content/quadrivalent-hpv-vaccine-found-effective-males-1
Mary Ann Moon

Feb 2nd, 2011 - The quadrivalent human papillomavirus vaccine prevents the infection as well as the development of external anogenital lesions associated with the virus in boys and men, according to a report in the Feb. 3 issue of the New England Journal of Medic.

Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis: A Review of the Literature
https://www.medscape.com/viewarticle/507662_1

Abstract and Introduction Recurrent respiratory papillomatosis (RRP) is a rare but potentially severe disease caused by papillomavirus, most often types 6 and 11. The disease, which occurs in both juvenile and adult forms, is characterized by beni...

Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis: A Review of the Literature
https://www.medscape.com/viewarticle/507662_2

Epidemiology Accurate epidemiologic data for RRP are not available. The incidence of RRP among children in the United States was estimated at 4.3/100,000 children, based on a survey questionnaire administered in 1993 to board-certified U.S. otolar...

Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis: A Review of the Literature
https://www.medscape.com/viewarticle/507662

Abstract and Introduction Recurrent respiratory papillomatosis (RRP) is a rare but potentially severe disease caused by papillomavirus, most often types 6 and 11. The disease, which occurs in both juvenile and adult forms, is characterized by beni...

see more →

Patient Education  2 results see all →